- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2012 (2012), Article ID 597637, 5 pages
The Effect of Bradykinin B2 Receptor Polymorphisms on the Susceptibility and Severity of Osteoarthritis in a Chinese Cohort
Department of Orthopedics Surgery, Tangdu Hospital, The Fourth Military Medical University, Xi'an 710038, China
Received 13 April 2012; Accepted 12 June 2012
Academic Editor: Thomas Liehr
Copyright © 2012 Shuo Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- R. Forestier, A. Francon, V. Briole, C. Genty, X. Chevalier, and P. Richette, “Prevalence of generalized osteoarthritis in a population with knee osteoarthritis,” Joint Bone Spine, vol. 78, no. 3, pp. 275–278, 2011.
- L. Busija, L. Bridgett, S. R. M. Williams, et al., “Osteoarthritis,” Best Practice & Research Clinical Rheumatology, vol. 24, no. 6, pp. 757–768, 2010.
- P. de Grandmont, “Osteoarthrosis/osteoarthritis in the temporomandibular joints,” The International Journal of Prosthodontics, vol. 22, no. 5, pp. 530–532, 2009.
- W. E. Horton Jr., P. Bennion, and L. Yang, “Cellular, molecular, and matrix changes in cartilage during aging and osteoarthritis,” Journal of Musculoskeletal Neuronal Interactions, vol. 6, no. 4, pp. 379–381, 2006.
- J. Pang, Y. L. Cao, and Y. Y. Shi, “Subchondral bone in osteoarthritis: a review,” Zhongguo Gu Shang, vol. 24, no. 8, pp. 702–704, 2011.
- S. Esser and A. Bailey, “Effects of exercise and physical activity on knee osteoarthritis,” Current Pain and Headache Reports, vol. 15, no. 6, pp. 423–430, 2011.
- J. Y. Bae, K. S. Park, J. K. Seon, et al., “Biomechanical analysis of the effects of medial meniscectomy on degenerative osteoarthritis,” Medical and Biological Engineering and Computing, vol. 50, no. 1, pp. 53–60, 2012.
- D. D. Anderson, J. L. Marsh, and T. D. Brown, “The pathomechanical etiology of post-traumatic osteoarthritis following intraarticular fractures,” The Iowa Orthopaedic Journal, vol. 31, pp. 1–20, 2011.
- L. Michou, “Genetics of digital osteoarthritis,” Joint Bone Spine, vol. 78, no. 4, pp. 347–351, 2011.
- S. J. Lee, M.-J. Kim, S.-J. Kee, et al., “Association study of the candidate gene for knee osteoarthritis in Koreans,” Rheumatology International. In press.
- S. Ikegawa, “Recent advance in the genomic study for osteoarthritis,” Clinical Calcium, vol. 21, no. 6, pp. 826–830, 2011.
- M. B. Goldring and M. Otero, “Inflammation in osteoarthritis,” Current Opinion in Rheumatology, vol. 23, no. 5, pp. 471–478, 2011.
- S. B. Abramson, “Inflammation in osteoarthritis,” The Journal of Rheumatology, vol. 70, pp. 70–76, 2004.
- M. J. Benito, D. J. Veale, O. FitzGerald, W. B. van den Berg, and B. Bresnihan, “Synovial tissue inflammation in early and late osteoarthritis,” Annals of the Rheumatic Diseases, vol. 64, no. 9, pp. 1263–1267, 2005.
- A. Dray and M. Perkins, “Bradykinin and inflammatory pain,” Trends in Neurosciences, vol. 16, no. 3, pp. 99–104, 1993.
- A. B. Brechter and U. H. Lerner, “Bradykinin potentiates cytokine-induced prostaglandin biosynthesis in osteoblasts by enhanced expression of cyclooxygenase 2, resulting in increased RANKL expression,” Arthritis and Rheumatism, vol. 56, no. 3, pp. 910–923, 2007.
- L. Bouillet, I. Boccon-Gibod, and C. Massot, “Bradykinin mediated angioedema,” Revue de Medecine Interne, vol. 32, no. 4, pp. 225–231, 2011.
- S. Meini, P. Cucchi, C. Catalani, F. Bellucci, S. Giuliani, and C. A. Maggi, “Bradykinin and B2 receptor antagonism in rat and human articular chondrocytes,” British Journal of Pharmacology, vol. 162, no. 3, pp. 611–622, 2011.
- N. Warde, “Osteoarthritis: local antagonism of endothelin-1 and bradykinin receptors improves OA pain and joint morphology in rats,” Nature Reviews Rheumatology, vol. 7, no. 7, p. 375, 2011.
- E. Y. Chen, D. F. Emerich, R. T. Bartus, et al., “B2 bradykinin receptor immunoreactivity in rat brain,” The Journal of Comparative Neurology, vol. 427, no. 1, pp. 1–18, 2000.
- B. Cassim, S. Naidoo, R. Ramsaroop, and K. D. Bhoola, “Immunolocalization of bradykinin receptors on human synovial tissue,” Immunopharmacology, vol. 36, no. 2-3, pp. 121–125, 1997.
- F. Bellucci, P. Cucchi, C. Catalani, S. Giuliani, S. Meini, and C. A. Maggi, “Novel effects mediated by bradykinin and pharmacological characterization of bradykinin B2 receptor antagonism in human synovial fibroblasts,” British Journal of Pharmacology, vol. 158, no. 8, pp. 1996–2004, 2009.
- F. Fallo, P. Mulatero, R. Vettor et al., “Bradykinin B2 receptor gene C-58T polymorphism and insulin resistance. A study on obese patients,” Hormone and Metabolic Research, vol. 36, no. 4, pp. 243–246, 2004.
- W. Niu, Y. Qi, P. Gao, and D. Zhu, “A meta-analysis of the bradykinin B2 receptor gene—58C/T polymorphism with hypertension,” Clinica Chimica Acta, vol. 411, no. 5-6, pp. 324–328, 2010.
- Y. Fu, T. Katsuya, A. Matsuo et al., “Relationship of bradykinin B2 receptor gene polymorphism with essential hypertension and left ventricular hypertrophy,” Hypertension Research, vol. 27, no. 12, pp. 933–938, 2004.
- Y. J. Lee and J. C. R. Tsai, “Angiotensin-converting enzyme gene insertion/deletion, not bradykinin B2 receptor—58T/C gene polymorphism, associated with angiotensin-converting enzyme inhibitor-related cough in Chinese female patients with non-insulin-dependent diabetes mellitus,” Metabolism, vol. 50, no. 11, pp. 1346–1350, 2001.
- R. Altman, E. Asch, and D. Bloch, “Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee,” Arthritis and Rheumatism, vol. 29, no. 8, pp. 1039–1052, 1986.
- P. Wang, M. S. Koehle, and J. L. Rupert, “No association between alleles of the bradykinin receptor-B2 gene and acute mountain sickness,” Experimental Biology and Medicine, vol. 235, no. 6, pp. 737–740, 2010.
- S. Meini and C. A. Maggi, “Knee osteoarthritis: a role for bradykinin?” Inflammation Research, vol. 57, no. 8, pp. 351–361, 2008.
- H. Cambridge and S. D. Brain, “Kinin B2 and B1 receptor-mediated vasoactive effects in rabbit synovium,” Peptides, vol. 19, no. 3, pp. 569–576, 1998.
- L. Taraseviciene-Stewart, R. Scerbavicius, J. M. Stewart et al., “Treatment of severe pulmonary hypertension: a bradykinin receptor 2 agonist B9972 causes reduction of pulmonary artery pressure and right ventricular hypertrophy,” Peptides, vol. 26, no. 8, pp. 1292–1300, 2005.
- J. R. Cockcroft, P. J. Chowienczyk, S. E. Brett, N. Bender, and J. M. Ritter, “Inhibition of bradykinin-induced vasodilation in human forearm vasculature by icatibant, a potent B2-receptor antagonist,” British Journal of Clinical Pharmacology, vol. 38, no. 4, pp. 317–321, 1994.
- J. X. Ma, D. Z. Wang, D. C. Ward et al., “Structure and chromosomal localization of the gene (BDKRB2) encoding human bradykinin B2 receptor,” Genomics, vol. 23, no. 2, pp. 362–369, 1994.
- S. J. Powell, G. Slynn, C. Thomas, B. Hopkins, I. Briggs, and A. Graham, “Human bradykinin B2 receptor: nucleotide sequence analysis and assignment to chromosome 14,” Genomics, vol. 15, no. 2, pp. 435–438, 1993.
- S. Kammerer, A. Braun, N. Arnold, and A. A. Roscher, “The human bradykinin B2 receptor gene: full length cDNA, genomic organization and identification of the regulatory region,” Biochemical and Biophysical Research Communications, vol. 211, no. 1, pp. 226–233, 1995.
- S. S. Dhamrait, J. R. Payne, P. Li et al., “Variation in bradykinin receptor genes increases the cardiovascular risk associated with hypertension,” European Heart Journal, vol. 24, no. 18, pp. 1672–1680, 2003.
- T. P. Olson, R. P. Frantz, S. T. Turner, et al., “Gene variant of the bradykinin B2 receptor influences pulmonary arterial pressures in heart failure patients,” Clinical Medicine. Circulatory, Respiratory and Pulmonary Medicine, vol. 2009, no. 3, pp. 9–17, 2009.
- D. Brull, S. Dhamrait, S. Myerson et al., “Bradykinin B2BKR receptor polymorphism and left-ventricular growth response,” The Lancet, vol. 358, no. 9288, pp. 1155–1156, 2001.